Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.

Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL.

Psychopharmacology (Berl). 2009 Jul;205(1):119-28. doi: 10.1007/s00213-009-1521-8. Epub 2009 Apr 1.

2.

Focus on amisulpride.

Green B.

Curr Med Res Opin. 2002;18(3):113-7. Review.

PMID:
12094819
3.

Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.

Möller HJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1101-11. Review.

PMID:
14642970
4.

Amisulpride: from animal pharmacology to therapeutic action.

Scatton B, Claustre Y, Cudennec A, Oblin A, Perrault G, Sanger DJ, Schoemaker H.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S29-36. Review.

PMID:
9218165
5.

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.

Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G.

Hum Psychopharmacol. 2002 Jan;17(1):1-13. Review.

PMID:
12404702
6.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
7.

The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.

Cryan JF, Mombereau C, Vassout A.

Neurosci Biobehav Rev. 2005;29(4-5):571-625. Review.

PMID:
15890404
8.

The 5-HT7 receptor and disorders of the nervous system: an overview.

Hedlund PB.

Psychopharmacology (Berl). 2009 Oct;206(3):345-54. doi: 10.1007/s00213-009-1626-0. Epub 2009 Aug 1. Review.

Supplemental Content

Support Center